Hengrui Medicine: Senior Vice President Sun Jieping plans to reduce his stake in the company by no more than 0.007%.

On June 15th, Hengrui Medicine announced that due to personal funding needs, Director and Senior Vice President Sun Jieping plans to reduce his holdings of company shares through centralized bidding trading within 3 months after 15 trading days from the disclosure date of this announcement, with a total reduction of no more than 476,700 shares, which is not more than 25% of his own holdings, and not more than 0.007% of the total share capital of the company. The reduction price will be determined based on the market price at the time of the reduction. As of the disclosure date of this announcement, Sun Jieping holds 1,907,032 shares of the company, accounting for 0.029% of the total share capital of the company.